Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Additionally we are shipping Keratin 17 Kits (36) and Keratin 17 Proteins (11) and many more products for this protein.
Showing 10 out of 336 products:
Human Monoclonal KRT17 Primary Antibody for ICC, FACS - ABIN335340
Guelstein, Tchypysheva, Ermilova, Litvinova, Troyanovsky, Bannikov: Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. in International journal of cancer. Journal international du cancer 1988
Show all 10 Pubmed References
Human Monoclonal KRT17 Primary Antibody for IHC, ELISA - ABIN965900
van de Rijn, Perou, Tibshirani, Haas, Kallioniemi, Kononen, Torhorst, Sauter, Zuber, Köchli, Mross, Dieterich, Seitz, Ross, Botstein, Brown: Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. in The American journal of pathology 2002
Show all 2 Pubmed References
Human Monoclonal KRT17 Primary Antibody for IF, IHC (p) - ABIN561630
Turashvili, Bouchal, Baumforth, Wei, Dziechciarkova, Ehrmann, Klein, Fridman, Skarda, Srovnal, Hajduch, Murray, Kolar: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. in BMC cancer 2007
Human Monoclonal KRT17 Primary Antibody for IHC (p), ELISA - ABIN561631
Anagnostou, Dimou, Botsis, Killiam, Gustavson, Homer, Boffa, Zolota, Dougenis, Tanoue, Gettinger, Detterbeck, Syrigos, Bepler, Rimm: Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay. in Cancer 2012
Human Polyclonal KRT17 Primary Antibody for IHC, IHC (p) - ABIN4302502
Kiflemariam, Andersson, Asplund, Pontén, Sjöblom: Scalable in situ hybridization on tissue arrays for validation of novel cancer and tissue-specific biomarkers. in PLoS ONE 2012
Cow (Bovine) Monoclonal KRT17 Primary Antibody for ELISA, FACS - ABIN4302506
Haisma, Rietveld, de Breij, van Dissel, El Ghalbzouri, Nibbering: Inflammatory and antimicrobial responses to methicillin-resistant Staphylococcus aureus in an in vitro wound infection model. in PLoS ONE 2013
Human Monoclonal KRT17 Primary Antibody for IHC (fro), IHC (p) - ABIN1106915
Hachiya, Sriwiriyanont, Fujimura, Ohuchi, Kitahara, Takema, Kitzmiller, Visscher, Tsuboi, Boissy: Mechanistic effects of long-term ultraviolet B irradiation induce epidermal and dermal changes in human skin xenografts. in The American journal of pathology 2009
Human Monoclonal KRT17 Primary Antibody for IHC, ELISA - ABIN969058
Leigh, Navsaria, Purkis, McKay, Bowden, Riddle: Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. in The British journal of dermatology 1995
Show all 2 Pubmed References
Human Polyclonal KRT17 Primary Antibody for IHC (fro), IHC (p) - ABIN126071
Demirkesen, Hoede, Moll: Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins. in Journal of cutaneous pathology 1996
Show all 2 Pubmed References
Krt17 was demonstrated to contribute to areca nut-induced oral malignancy
TGFbeta (show TGFB1 Antibodies)/SMAD (show SMAD1 Antibodies)/miR (show MLXIP Antibodies)-486-3p signaling axis in keratinocytes regulated K17 expression and cell proliferation. We conclude that the loss of miR (show MLXIP Antibodies)-486-3p in psoriatic epidermis leads to K17 protein overexpression and contributes to the pathogenesis of psoriasis.
inflammatory cytokines promoted Nrf2 (show GABPA Antibodies) nuclear translocation in psoriatic epidermis, which led to elevated expression of K6, K16 (show KRT16 Antibodies), and K17, thus promoting keratinocyte proliferation and contributing to the pathogenesis of psoriasis.
KRT17 promotes tumor cell growth, at least partially, through its anti-apoptotic effect as a result of the KRT17 overexpression by GLIs in oral squamous cell carcinoma (OSCC)..
TGF-beta1 (show TGFB1 Antibodies)-induced CK17 enhances cancer stem cell-like properties rather than epithelial-mesenchymal transition in promoting cervical cancer metastasis via the ERK1/2 (show MAPK1/3 Antibodies)-MZF1 (show ZFP42 Antibodies) signaling pathway.
K17 is highly expressed in most cases of both invasive adenocarcinoma and in AIS (show AR Antibodies) and is a powerful, negative prognostic marker for patient survival.
the data suggest that the loss of Krt17 may foster an overall protective environment for lesion-prone cervical tissue.
K17 is expressed in a subset of triple-negative breast cancers, and is a marker of poor prognosis in patients with advanced stage and ER(-)/HER2 (show ERBB2 Antibodies)(-) breast cancer.
MiR (show MLXIP Antibodies)-138 may regulate K17 protein expression to affect cell proliferation and apoptosis by targeting hTERT gene in keratinocytes from psoriatic vulgaris patients.
The pattern of CK17 expression is a highly sensitive marker for distinguishing cutaneous lymphadenoma from basal cell carcinoma in small samples.
TGF-beta1 (show TGFB1 Antibodies)-induced CK17 enhances cancer stem cell-like properties rather than epithelial-mesenchymal transition in promoting cervical cancer metastasis via the ERK1/2 (show MAPK1/3 Antibodies)-MZF1 (show ZSCAN1 Antibodies) signaling pathway.
p53 (show TP53 Antibodies) operates as a direct Krt17 repressor that invites therapeutic targeting in radiodermatitis .
genetic loss of caspase-7 (show CASP7 Antibodies) promotes solar-simulated light-induced skin carcinogenesis by blocking caspase-7 (show CASP7 Antibodies)-mediated cleavage of keratin-17.
Data indicate that keratin 17 (k17) regulates autoimmune regulator Aire (show AIRE Antibodies) to promote skin tumorigenesis.
These findings functionally integrate K17, hnRNP K (show HNRNPK Antibodies), and gene expression along with RSK (show RPS6KA1 Antibodies) and CXCR3 (show CXCR3 Antibodies) signaling in a keratinocyte-autonomous axis and provide a potential basis for their implication in tumorigenesis
KRT17 is necessary for oncogenic transformation in Ewing sarcoma and accounts for much of the GLI1 (show GLI1 Antibodies)-mediated transformation function but via a mechanism independent of AKT (show AKT1 Antibodies) signaling.
Cytochrome b5 (show CYB5A Antibodies) and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury.
IL-22 (show IL22 Antibodies) up-regulates K17 expression in keratinocytes in a dose-dependent manner through STAT3 (show STAT3 Antibodies)- and ERK1/2 (show MAPK1/3 Antibodies)-dependent mechanisms.
Type I keratin (show KRT12 Antibodies) 17 protein is phosphorylated on serine 44 by p90 (show GPAM Antibodies) ribosomal protein S6 kinase 1 (RSK1 (show RPS6KA1 Antibodies)) in a growth- and stress-dependent fashion
This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
, keratin 17 epitope S1
, keratin 17 epitope S2
, keratin 17 epitope S4
, keratin, type I cytoskeletal 17
, type I keratin KA17
, keratin complex 1, acidic, gene 17
, keratin 17
, keratin 16
, Keratin, type I cytoskeletal 17